Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107 USD
0.1%
Updated:
Apr 25, 2024
Abbott Laboratories
Operating Income
|
Abbott Laboratories
Operating Income Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Operating Income
$1.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Abbott Laboratories's Operating Income?
Operating Income
6.6B
USD
6.6B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Operating Income amounts to 6.6B USD.
What is Abbott Laboratories's Operating Income growth rate?
Operating Income CAGR 10Y
13%
13%
Over the last year, the Operating Income growth was -6%. The average annual Operating Income growth rates for Abbott Laboratories have been -1% over the past three years , 11% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
